Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?

Zacks
在Zacks上打开
Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Concentra Group (CON) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

Concentra Group is a member of our Medical group, which includes 916 different companies and currently sits at #8 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Concentra Group is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for CON's full-year earnings has moved 8.4% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Based on the most recent data, CON has returned 103.3% so far this year. At the same time, Medical stocks have gained an average of 5.3%. This means that Concentra Group is performing better than its sector in terms of year-to-date returns.

Centene (CNC) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 67%.

For Centene, the consensus EPS estimate for the current year has increased 6.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Looking more specifically, Concentra Group belongs to the Medical Services industry, which includes 70 individual stocks and currently sits at #148 in the Zacks Industry Rank. On average, this group has gained an average of 8.4% so far this year, meaning that CON is performing better in terms of year-to-date returns.

In contrast, Centene falls under the Medical - HMOs industry. Currently, this industry has 7 stocks and is ranked #22. Since the beginning of the year, the industry has moved +25.8%.

Investors with an interest in Medical stocks should continue to track Concentra Group and Centene. These stocks will be looking to continue their solid performance.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Concentra Group Holdings Parent, Inc. (CON): Free Stock Analysis Report
 
Centene Corporation (CNC): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research